SSA
ELV icon

Schonfeld Strategic Advisors’s Elevance Health ELV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,000
Closed -$4.33M – 2136
2024
Q2 		$4.33M Buy
+8,000
New +$4.23M 0.03% 598

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Schonfeld Strategic Advisors's ELV Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Elevance Health (ELV) stake by 3,477% in Q1 2026, buying an estimated $26.8M and bringing the position to 83,877 shares worth $24.6M. The position accounts for 0.17% of the portfolio, ranked #111.

Schonfeld Strategic Advisors first reported a position in ELV in Q2 2017 and has held it in 31 quarters since. The position peaked at $47.5M in Q3 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Schonfeld Strategic Advisors held 83,877 shares of Elevance Health worth $24.6M as of Q1 2026.
  • Schonfeld Strategic Advisors bought 81,532 Elevance Health shares in Q1 2026, an estimated $26.8M.
  • Elevance Health made up 0.17% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #111 holding.
  • Schonfeld Strategic Advisors first reported a position in Elevance Health in Q2 2017 and has held it in 31 quarters since.
  • Schonfeld Strategic Advisors's Elevance Health position peaked at $47.5M in Q3 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.